Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4

Author(s):
Krzysztof DomagalskiKrzysztof Domagalski2, Ma?gorzata PawlowskaMa?gorzata PawlowskaMa?gorzata Pawlowska ORCID1,*, Andrzej TretynAndrzej Tretyn3, Waldemar HalotaWaldemar Halota1, Malgorzata TyczynoMalgorzata Tyczyno1, Dorota KozielewiczDorota Kozielewicz1, Dorota DybowskaDorota Dybowska1
2Department of Plant Physiology and Biotechnology, Nicolaus Copernicus University, Torun, Poland
1Department of Infectious Diseases and Hepatology, Nicolaus Copernicus University, Bydgoszcz, Poland
3Centre For Modern Interdisciplinary Technologies, Nicolaus Copernicus University, Torun, Poland
*Corresponding Author: Department of Infectious Diseases and Hepatology, Nicolaus Copernicus University, Bydgoszcz, Poland. Tel/Fax: +48-523255605, [email protected]. Email: [email protected]

Hepatitis Monthly:Vol. 13, issue 11; 13678
Published online:Nov 24, 2013
Article type:Research Article
Received:Jul 17, 2013
Accepted:Nov 03, 2013
How to Cite:Domagalski K, Pawlowska M, Tretyn A, Halota W, Tyczyno M, et al. Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4. Hepat Mon. 2013;13(11):13678. doi: https://doi.org/10.5812/hepatmon.13678

Abstract

Background:

Three single nucleotide polymorphisms (SNPs) near interleukin-28B (IL-28B) gene were shown to be highly associated with treatment response (SVR) in patients with chronic hepatitis C virus (HCV) infection. There is limited data about the role of single and combined IL-28B polymorphisms in HCV-infected Polish population.

Objectives:

This study's aim was to determine predictability of three IL-28B gene polymorphisms and other known prognostic factors on the treatment response in HCV genotype 1 and 4 infected Polish patients. The effect of IL-28B polymorphisms on therapy was also compared with other known prognostic factors.

Patients and Methods:

We genotyped IL-28B polymorphisms (rs12979860, rs12980275 and rs8099917) by polymerase chain reaction-based restriction fragment length polymorphism assay in a group of 293 patients from which a selected cohort of 174 treatment-nave patients underwent treatment.

Results:

We showed that rs12979860 CC [odds ratio (OR) = 4.6, P < 0.001], rs12980275 AA (OR = 2.9, P = 0.002) and rs8099917 TT (OR = 2.2, p = 0.016) genotypes were associated with successful treatment compared to the rs12979860 CT-TT, rs12980275 AG-GG and rs8099917 TG-GG, respectively. Patients bearing of IL28B profile including the three favourable genotypes do not have much chance of a recovery (OR = 3.4, P = 0.002). Except for IL-28B polymorphisms, there was no association of SVR with any other pretreatment clinical data in analyzed group. The correlation of SNPs with other host and viral factors revealed association of favorable genotypes of IL-28B markers with high levels of alanine aminotransferase and baseline HCV viral load.

Conclusions:

IL-28B polymorphisms were the strongest pretreatment predictors of response to pegylated interferon and ribavirin in Polish patients chronically infected with HCV genotype 1 and 4. This study confirm the strongest impact of IL-28B rs12979860 on SVR, nevertheless rs12980275 AA seems to be more important than rs8099917 TT in predicting positive treatment response.

Full Text

Full text is available in PDF

Copyright

© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

18
Dec
2016

Genetic Variation in Interleukin-28B and Response to Peg-IFNα-2a/RBV Combination Therapy in Patients with Hepatitis C Virus Infection

Farah Bokharaei-Salim,
Mostafa Salehi-Vaziri,
Farzin Sadeghi,
Khadijeh Khanaliha,
Maryam Esghaei,
Seyed Hamidreza Monavari
,et al.

Bokharaei-Salim F, Salehi-Vaziri M, Sadeghi F, Khanaliha K, Esghaei M, et al. Genetic Variation in Interleukin-28B and Response to Peg-IFNα-2a/RBV Combination Therapy in Patients with Hepatitis C Virus Infection. Jundishapur J Microbiol. 2017;10(1):e39178. doi: https://doi.org/10.5812/jjm.39178

2
Jun
2020
Jundishapur Journal of Microbiology

The Study of IFNL3 Gene Rs12979860 Polymorphism in the Hepatitis C Virus Patients and Healthy Population in Tehran Province, Iran

Mohsen Koolivand,
Zeinab Allamehzadeh,
Ali Ahmadi,
Ramezan Ali Taheri,
Kazem Hassanpour,
Afshin Zeini
,et al.

Koolivand M, Allamehzadeh Z, Ahmadi A, Taheri RA, Hassanpour K, et al. The Study of IFNL3 Gene Rs12979860 Polymorphism in the Hepatitis C Virus Patients and Healthy Population in Tehran Province, Iran. Jundishapur J Microbiol. 2020;13(5):e95798. doi: https://doi.org/10.5812/jjm.95798

14
Sep
2016

The Effect of IL28B Gene Polymorphism on Treatment Response in Iranian Patients with Hepatitis C Virus Infection

Fateme Zare,
Hossein Hadinedoushan,
Mohsen Akhondi Meybodi,
Mahdi Dehghanmanshadi,
Seyyed Ali Mirghanizade Bafghi,
Mahmood Vakili

Zare F, Hadinedoushan H, Akhondi Meybodi M, Dehghanmanshadi M, Mirghanizade Bafghi SA, et al. The Effect of IL28B Gene Polymorphism on Treatment Response in Iranian Patients with Hepatitis C Virus Infection. Jundishapur J Microbiol. 2016;9(12):e31501. doi: https://doi.org/10.5812/jjm.31501

9
Aug
2014

The Role of Interleukin-28b Gene Polymorphisms in Chinese Patients With Chronic Hepatitis C Treated With Pegylated Interferon and Ribavirin

Yin Mi,
Ying Tang Gao,
Xiao Lei Jiao,
Hua Guo,
Tong Liu,
Li Jing
,et al.

Mi Y, Gao YT, Jiao XL, Guo H, Liu T, et al. The Role of Interleukin-28b Gene Polymorphisms in Chinese Patients With Chronic Hepatitis C Treated With Pegylated Interferon and Ribavirin. Hepat Mon. 2014;14(8):e18793. doi: https://doi.org/10.5812/hepatmon.18793

31
Dec
2011

The Correlation of Il28B Genotype With Sustained Virologic Response In Romanian patients With Chronic Hepatitis C

Ioan Sporea,
Alina Popescu,
Manuela Curescu,
Roxana Sirli,
Isabel Dan,
Adrian Goldis
,et al.

Sporea I, Popescu A, Curescu M, Sirli R, Dan I, et al. The Correlation of Il28B Genotype With Sustained Virologic Response In Romanian patients With Chronic Hepatitis C. Hepat Mon. 2011;11(12):. doi: https://doi.org/10.5812/kowsar.1735143X.793

Download PDF141.93 KB

Crossmark

Crossmark

Checking

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles